Proof of Concept: Microinvasive AngioVac Approach in Renal Cell Carcinoma With Atrial Thrombosis.
Ann Thorac Surg
; 112(3): e193-e196, 2021 09.
Article
em En
| MEDLINE
| ID: mdl-33676906
The AngioVac system (AngioDynamics, Latham, NY) has already been described for treatment of thrombotic formations concerning the venous district and the tricuspid valve. We describe an innovative application of the AngioVac system to treat the inferior vena cava thrombosis associated with renal cell carcinoma. In a high surgical risk patient, we utilized a microinvasive and a modified venoarterial AngioVac circuit to remove the atrial thrombus, ensure temporary circulatory support during abdominal surgery, and prevent pulmonary embolism.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Veia Cava Inferior
/
Carcinoma de Células Renais
/
Cardiopatias
/
Neoplasias Renais
/
Células Neoplásicas Circulantes
Tipo de estudo:
Prognostic_studies
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article